Cognizant signs service agreement with AstraZeneca

The contract is for a period of five years with anticipated revenues of approximately $95 million. Under this agreement, Cognizant will provide a broad spectrum of centralized data management services for AstraZeneca’s global clinical development programs, including data management planning, clinical study set-up for electronic data capture, medical coding, adverse event reconciliation, clinical data management, and training for the clinical sites and investigators.

Anders Ekblom, vice president of clinical development, AstraZeneca, said: “Our existing, long-standing relationship with Cognizant supports our view that they are the best partner to deliver clinical data management services for us. Delivering efficiencies through reshaping our business is one of our key strategic priorities.”